MIT Launches Human Trials for 40Hz Sensory Therapy After Breakthrough in Down Syndrome Mice

The GENUS protocol, shown to improve memory, neurogenesis, and synaptic connectivity in mice, is now being tested for its potential benefits in people with Down syndrome.